Limited Stage Small Cell Lung Cancer Clinical Trials

41 clinical trials for Limited Stage Small Cell Lung Cancer across international registries, including 16 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Durvalumab Consolidation After Chemoradiation Therapy for Limited Stage SCLC in China — RECRUITING
• A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Tarlatamab Therapy in Subjects With Limited-Stage Small-Cell Lung Cancer (LS SCLC) who Have not Progressed Following Concurrent Chemoradiation Therapy (DeLLphi-306) — RECRUITING · PHASE3
• Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC) — RECRUITING · PHASE3
• Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients — RECRUITING · PHASE2
• Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer — RECRUITING · PHASE3
• A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy — RECRUITING · PHASE2
• MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer — RECRUITING · PHASE2
• BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS) — RECRUITING · PHASE2
• Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer — RECRUITING · PHASE2
• Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC) — RECRUITING · PHASE2
• Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy — RECRUITING
• Adjuvant Adebrelimab Plus Apatinib After Chemoradiation in Limited-Stage Small Cell Lung Cancer — RECRUITING · PHASE2
• Neoadjuvant Therapy With Toripalimab and JS004 Combined With Etoposide and Platinum Chemotherapy for Limited-stage Small Cell Lung Cancer : A Phase 2 Trial — RECRUITING · PHASE2
• PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study) — RECRUITING · NA
• Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT — RECRUITING · PHASE2
• Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cell Lung Cancer Who Achieved Remission After First-line Chemoradiotherapy — RECRUITING · PHASE3
• Tarlatamab and Durvalumab vs. Durvalumab Alone for Limited-Stage-Small Cell Lung Cancer — NOT_YET_RECRUITING · PHASE3
• Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) — ACTIVE_NOT_RECRUITING · PHASE3
• Benmelstobart Plus Anlotinib, Chemotherapy and Thoracic Radiation for Limited-Stage Small Cell Lung Cancer — NOT_YET_RECRUITING · PHASE2
• A Prospective, Multicenter Exploratory Clinical Study on Consolidation Therapy With Tislelizumab Combined With Nintedanib for Limited-stage Small Cell Lung Cancer — NOT_YET_RECRUITING · PHASE4
• A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer — ACTIVE_NOT_RECRUITING · PHASE3
• Adebrelimab Plus Chemoradiotherapy Followed by Adebrelimab Maintenance in Limited-Stage SCLC — NOT_YET_RECRUITING · PHASE2
• This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Combined With Chemotherapy With or Without Anlotinib in Resectable Limited-Stage Small Cell Lung Cancer — NOT_YET_RECRUITING · PHASE2
• Hypofractionated Radiotherapy Followed by Chemo-immunotherapy Induction Therapy — NOT_YET_RECRUITING · PHASE2
• Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease — COMPLETED · PHASE2
• Study of Ociperlimab Plus Tislelizumab Plus Chemoradiotherapy in Participants With Untreated Limited-Stage Small Cell Lung Cancer — COMPLETED · PHASE2
• An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung Cancer — WITHDRAWN · PHASE1
• A Study of HS-20093 vs Active Surveillance in Limited-Stage Small Cell Lung Cancer — NOT_YET_RECRUITING · PHASE3
• Consolidation Serplulimab Following Concurrent Chemoradiotherapy for LS-SCLC Patients — OTHER · PHASE2
• PD-L1/PD-1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone for the Neoadjuvant Treatment of Limited-stage SCLC — NOT_YET_RECRUITING · PHASE2
• Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer — COMPLETED · PHASE1
• A Phase Ib Study of TQB2450 Combined With Anlotinib in Patients With Limited Stage Small Cell Lung Cancer After First-line Radiotherapy and Chemotherapy — OTHER · PHASE1
• The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung Cancer — NOT_YET_RECRUITING · PHASE3
• Pamiparib for Consolidation Treatment of Unprogressed LS-SCLC After Concurrent Chemoradiotherapy — OTHER · PHASE2
• Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers — COMPLETED · PHASE2
• Durvalumab With Chemotherapy Followed by Sequential Radiotherapy for Limited Stage Small Cell Lung Cancer — OTHER · PHASE2
• Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients — COMPLETED · NA
• Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer — COMPLETED · PHASE1
• Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer — COMPLETED · PHASE2
• Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy — TERMINATED · PHASE2
• Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer — COMPLETED · PHASE2

Refine this search